ADDvise receives allocation decision from Kuopio University Hospital in Finland worth 1.8 MSEK
ADDvise Finnish subsidiary LabRum Klimat OY has received an allocation decision regarding delivering a NanoZoomer (a digital slide scanner) from Hamamatsu to Kuopio University Hospital in Finland. The product will be used in the hospital's pathology department. The order amounts to 1.8 MSEK.
The agreement has a standstill period until 17 February 2017. Not until then LabRum Klimat OY has the right to sign the agreement with Kuopio University Hospital.
- We are making progress on the Finnish market through our Finnish subsidiary, and I see great potential to gain further market share, says Rikard Akhtarzand, CEO of ADDvise Group, in a comment.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on February 15th 2017 at 14:40 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.